Le, Thi Yen, Thi Lan Anh Dinh, Thi Thao Le, Xuan Dai Nguyen, and Hoang Anh Nguyen. 2026. “FIRST-LINE TREATMENT OUTCOMES OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: SINGLE-CENTER REAL-WORLD DATA FROM VIETNAM, FROM 2020 TO 2026”. Journal of Military Pharmaco-Medicine 51 (8):152-61. https://doi.org/10.56535/jmpm.v51i8.2085.